TAM
ATRS

THB Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

THB Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-882,030
Closed -$3.94M – 260
2013
Q4 		$3.94M Sell
882,030
-235,170
-21% -$958K 0.22% 171
2013
Q3 		$4.54M Sell
1,117,200
-28,900
-3% -$126K 0.28% 147
2013
Q2 		$4.77M Buy
+1,146,100
New +$4.43M 0.32% 139

Other funds holding ATRS

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

THB Asset Management's ATRS Position: Q1 2014 in Review

THB Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2014, closing a stake of 882,030 shares — an estimated $3.94M sold.

THB Asset Management first reported a position in ATRS in Q2 2013 and held it in 3 quarters. The position peaked at $4.77M in Q2 2013. 91 funds tracked by Wall St. Rank hold ATRS as of Q1 2014.

  • THB Asset Management reported no remaining Antares Pharma, Inc. position as of Q1 2014 after selling out during the quarter.
  • THB Asset Management sold 882,030 Antares Pharma, Inc. shares in Q1 2014, an estimated $3.94M.
  • THB Asset Management first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 3 quarters.
  • THB Asset Management's Antares Pharma, Inc. position peaked at $4.77M in Q2 2013.
  • 91 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2014.

Based on THB Asset Management's 13F filing for Q1 2014, filed 22 Apr 2014.